BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 20, 2014
View Archived Issues
New approach to melanoma treatment: TR3-mediated autophagic cell death
Read More
Discovery of potent oral p53-Mdm2 inhibitors
Read More
Peanut allergy model created via bone marrow transplant
Read More
New study investigates third-generation CAR T-cell therapy with incorporated safety switch
Read More
Researchers at Merck & Co. design novel AMPK activators for diabetes
Read More
Array BioPharma and Genentech present new ERK inhibitors
Read More
Merck & Co. presents novel SYK inhibitors for the treatment of rheumatoid arthritis
Read More
Enrollment under way in Alcobra's phase III trial of MDX for adult ADHD
Read More
Compound library partnership established between Astellas and Daiichi Sankyo
Read More
Bristol-Myers Squibb presents data for BMS-903452
Read More
Sanofi Pasteur and SK Chemical collaborate on pneumococcal conjugate vaccine
Read More
biOasis Technologies, MedImmune sign agreement for second-generation brain delivery platform
Read More
TRPA1 antagonists described for the potential treatment of familial episodic pain syndrome
Read More
Chinese group presents novel agents for HIV and HBV infection
Read More
Researchers at the Virginia Commonwealth University disclose novel conjugates for cancer
Read More
Portola Pharmaceuticals begins phase III study of andexanet alfa
Read More
First patient enrolled in phase I study of AG-120
Read More
Dartmouth and Aeras to study new tuberculosis vaccine, DAR-901
Read More
Novel biomarker for colon cancer
Read More
Isis Pharmaceuticals begins phase I study of ISIS-ANGPTL3Rx to treat hyperlipidemia
Read More
AdvanDx submits application to FDA seeking approval of rapid MRSA test
Read More
Phase Ia results for HMS-5552 lead to initiation of phase Ib study
Read More
FDA approves Impavido for leishmaniasis
Read More
Emmaus Life Sciences reports topline data from phase III sickle cell disease trial
Read More
Merck & Co. initiates North American phase III development of SLIT tablet
Read More
Navidea Biopharmaceuticals discusses Lymphoseek MAA with EMA committee
Read More